Prosecution Insights
Last updated: April 19, 2026
Application No. 18/858,658

METHOD FOR ACQUIRING AND RECONSTRUCTING IMAGES OF A HEART IN FREE BREATHING, SYSTEM

Non-Final OA §103§112
Filed
Oct 21, 2024
Examiner
COOK, CHRISTOPHER L
Art Unit
3797
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Centre Hospitalier Universitaire Vaudois
OA Round
1 (Non-Final)
47%
Grant Probability
Moderate
1-2
OA Rounds
4y 7m
To Grant
74%
With Interview

Examiner Intelligence

Grants 47% of resolved cases
47%
Career Allow Rate
254 granted / 544 resolved
-23.3% vs TC avg
Strong +27% interview lift
Without
With
+27.4%
Interview Lift
resolved cases with interview
Typical timeline
4y 7m
Avg Prosecution
46 currently pending
Career history
590
Total Applications
across all art units

Statute-Specific Performance

§101
4.0%
-36.0% vs TC avg
§103
42.8%
+2.8% vs TC avg
§102
11.0%
-29.0% vs TC avg
§112
32.6%
-7.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 544 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 is rejected because it is unclear if “the same first inter-beat phase” (line 14) is the same as phase as the first phase previously set forth in line 4. Claim 1 is rejected because “the heart rhythm” (line 19), “the same inter-beat phase” (Lines 19-20) lack proper antecedent basis. Claim 1 is also rejected because the limitations “on the one hand” and “on the other hand” are indefinite and lack proper antecedent basis. Claim 1 is also rejected because it is unclear if the non-rigid registration algorithm applied to subset of second images is the same non-rigid registration algorithm applied to subset of first images. Claim 16 inherits all of Claim 1’s rejections. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-16 is/are rejected under 35 U.S.C. 103 as being unpatentable over U.S Publication No. 2017/0212195 to Rehwald et al. “Rehwald” in view of NPL “3D whole-heart phase sensitive inversion recovery CMR for simultaneous black-blood late gadolinium enhancement and bright blood coronary CMR angiography” to Ginami et al. “Ginami” and U.S. Publication No. 2021/0383537 to Chitiboi et al. “Chitiboi” or alternatively, U.S. Publication No. 2017/0076449 to Chow et al. “Chow”. With respect to Claims 1-2, 11-12, 14 and 16, Rehwald discloses a method for reconstructing an image of a patient’s heart from a magnetic resonance imaging (MRI) device (Abstract; Fig. 1 and corresponding descriptions; Paragraph [0027]) comprising acquiring ECG triggered image data (Fig. 5 and corresponding descriptions). Rehwald explains the image acquisition can be 2D or 3D (Paragraph [0035]. Regarding the sequence, following the R-wave in each ECG cycle (e.g. phase), an inversion pulse is provided to invert magnetization (202 in Fig. 2 and corresponding descriptions) followed by the imaging sequence (Paragraphs [0032], [0035], [0050] and Fig. 5 and corresponding descriptions). Rehwald also discloses where the preparation may use a combination of a leading T2-preparation (T2-prep) with a trailering IR pulse or a leading magnetization transfer pulse, or the combination of any other suitable preparation with trailing or leading IR pulse (Paragraph [0038]) and where the preparation module comprises a series of at least one T1(rho), T2(rho), or spin-lock contrast imparting pulse being followed or preceding the inversion pulse (Claim 24). Thus, Rehwald is considered to read on the claimed limitations of a first phase image generation comprising acquiring electrical activity (ECG) of the patients heart, generating a first 180o inversion radio frequency signal to inverse a longitudinal magnetization of tissues of an imaged area, the inversion being between two QRS complexes; generating a first magnetization preparation including a set of pulses following the generation of the first inversion pulse in the same first inter-beat phase, acquiring a first image by a magnetization measurement of the imaged area after a first predefined duration following the preparation and synchronized with the ECG (e.g. heart rhythm) in its broadest reasonable interpretation. Fig. 5 depicts a repeated image acquisition in a second inter-beat phase but with no inversion pulse. Thus, Rehwald is considered to read on the claimed limitations of generating a second magnetization preparation in a second inter-beat phase following the first inter-beat phase and acquiring a second image by a magnetization measurement of the second area in a second predefined duration synchronized with the ECT at the same time marker as the first image acquisitions in its broadest reasonable interpretations. Rehwald discloses the aforementioned steps can be accomplished in only two heartbeats, it may be repeated for any other suitable time period (Paragraph 0035]). However, Rehwald does not expressly disclose applying a “non-rigid” registration algorithm to each subset of first images and second images to separately register them together and to combine the registered first and second images together as claimed. Regarding combining images from different heart phases, Ginami teaches from within a similar field of endeavor with respect to cardiovascular MRI imaging systems and methods (Abstract) where black and bright blood images are collected separately, registered, and then combined to obtain complementary phase sensitive inversion recovery bright-blood and black-blood phase image (Page 2, “Methods”). While Ginami uses rigid registration, Ginami expressly suggests using non-rigid registration algorithms to improve the quality of the combined dataset (Page 12). Chitiboi teaches from within a similar field of endeavor with respect to late gadolinium enhancement MRI systems and methods (Paragraphs [0019]-[0021]) where rigid or elastic registration techniques are used (Paragraph [0025]). Alternatively, Chow teaches from within a similar filed of endeavor with respect to cardiac MRI imaging where images may be registered to one another with a non-rigid registration (Abstract; Paragraphs [0009] and [0018]). Accordingly, one skilled in the art would have been motivated to have modified the cardiac MRI system and method described by Rehwald to register and combine image acquisitions as described by Ginami in order to provide accurate cardiac images with improved visualization of cardiac anatomy (Ginami-Abstract). Furthermore, one skilled in the art would have been motivated to have used elastic (e.g. non-rigid) registration techniques described by Chitiboi/Chow in order to compensate for residual mis-registration errors. Such modifications merely involve combining prior art techniques to yield predictable results (MPEP 2143). Regarding Claim 3, Rehwald discloses averaging pixels within each portion (Paragraphs [0006] and [0055]). Accordingly, one skilled in the art would have been motivated to have averaged the registered images to produce the merged image in order to reduce errors and improve signal to noise ratio (Rehwald-Paragraph [0055]). As for Claim 4, Rehwald teaches where the delay between the IR pulse and the readout can be set to achieve nulling (Paragraphs [0004], [0025] and [0033]). With respect to Claim 5, Rehwald’s system calculates the optimal TI (Paragraph [0033]). With respect to Claims 6-7 and 9-10, Ginami displays black blood, bright blood and combined images (Fig. 5 and corresponding descriptions) and determines scar tissue locations based on the acquired data, the combined images use color to indicate the scarring (Fig. 7 and corresponding descriptions). Ginami explains the combined images are “fused” which would read on overlaying the bright and black blood images together in its broadest reasonable interpretation. As for Claim 8, Examiner notes repeating the modified imaging sequence as described above would read on the claimed steps in its broadest reasonable interpretation. Regarding Claim 13, both Rehwald and Gianami disclose fat suppression techniques (Rehwald-Paragraph [0025]; Gianami-Fig. 1 and corresponding descriptions) which is considered tor read on filtering fatty areas in its broadest reasonable interpretation. As for Claim 15, Rehwald depicts multiple acquisitions within each heart cycle (Fig. 5) and a plurality of images as a result (Fig. 6A). In addition, Chow explains that a plurality of images acquired inside heart cycles (Abstract; Figs. 4A; Paragraphs [0010], [0017] and [0062]). Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. U.S. Publication No. 2017/0030990 to Janich et al. which discloses cardiac MRI late gadolinium imaging can be done in 2D or 3D (Paragraph [0026]). Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTOPHER L COOK whose telephone number is (571)270-7373. The examiner can normally be reached M-F approximately 8AM-5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anne Kozak can be reached at 571-270-0552. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHRISTOPHER L COOK/Primary Examiner, Art Unit 3797
Read full office action

Prosecution Timeline

Oct 21, 2024
Application Filed
Mar 19, 2026
Non-Final Rejection — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594056
ULTRASOUND SYSTEM AND METHOD FOR CONTROLLING ULTRASOUND SYSTEM
2y 5m to grant Granted Apr 07, 2026
Patent 12569149
SYSTEM AND METHOD TO DETECT THE PRESENCE AND PROGRESSION OF DISEASES CHARACTERIZED BY SYSTEMIC CHANGES IN THE STATE OF THE VASCULATURE
2y 5m to grant Granted Mar 10, 2026
Patent 12569309
SYSTEMS AND METHODS FOR MONITORING PATIENT MOTION DURING A MEDICAL PROCEDURE
2y 5m to grant Granted Mar 10, 2026
Patent 12551129
SKULL-CONTOURED MRI LOCALIZER
2y 5m to grant Granted Feb 17, 2026
Patent 12529738
PATIENT-COMPLIANT MRI COIL EMPLOYING PATIENT ANATOMY FOR COIL LOCATION
2y 5m to grant Granted Jan 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
47%
Grant Probability
74%
With Interview (+27.4%)
4y 7m
Median Time to Grant
Low
PTA Risk
Based on 544 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month